Sarepta Therapeutics (SRPT) Granted FDA Accelerated Approval for Eteplirsen

September 19, 2016 9:51 AM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Sarepta Therapeutics (NASDAQ: SRPT) surges higher on FDA approval for eteplirsen

Letter from FDA



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

FDA, Hot FDA News, Management Changes, Trader Talk

Add Your Comment